Literature DB >> 26153722

Therapeutic Potential of Multipotent Mesenchymal Stromal Cells and Their Extracellular Vesicles.

Nina Heldring1, Imre Mäger2,3, Matthew J A Wood2, Katarina Le Blanc1, Samir E L Andaloussi1,2.   

Abstract

The therapeutic potential of mesenchymal stromal cells (MSCs) is evident by the number of new and ongoing trials targeting an impressive variety of conditions. In bone and cartilage repair, MSCs are expected to replace the damaged tissue, while in other therapies they modulate a therapeutic response by the secretion of bioactive molecules. MSCs possess a phenotypic plasticity and harbor an arsenal of bioactive molecules that can be released upon sensing signals in the local milieu either directly or packaged in extracellular vesicles (EVs). The reported paracrine effects comprise many of the important functions of MSCs, including supporting hematopoietic stem cells in the bone marrow, promoting angiogenesis, and modulating the immune system. The major drawback in MSC therapy is the incomplete understanding of cell fate following systemic administration as well as the mechanisms by which these cells correct disease. In this review we discuss what is known about MSC engraftment, hemocompatibility, and immunomodulation, as well as the potential of bringing the MSC-EV field toward a clinical translation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26153722     DOI: 10.1089/hum.2015.072

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  67 in total

1.  Chromatographically isolated CD63+CD81+ extracellular vesicles from mesenchymal stromal cells rescue cognitive impairments after TBI.

Authors:  Dong-ki Kim; Hidetaka Nishida; Su Yeon An; Ashok K Shetty; Thomas J Bartosh; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-22       Impact factor: 11.205

2.  Enabling mesenchymal stromal cell immunomodulatory analysis using scalable platforms.

Authors:  Evelyn Kendall Williams; José R García; Robert G Mannino; Rebecca S Schneider; Wilbur A Lam; Andrés J García
Journal:  Integr Biol (Camb)       Date:  2019-04-01       Impact factor: 2.192

Review 3.  Delivery of Therapeutic Proteins via Extracellular Vesicles: Review and Potential Treatments for Parkinson's Disease, Glioma, and Schwannoma.

Authors:  Justin Hall; Shilpa Prabhakar; Leonora Balaj; Charles P Lai; Richard A Cerione; Xandra O Breakefield
Journal:  Cell Mol Neurobiol       Date:  2016-03-26       Impact factor: 5.046

Review 4.  Strategies to enhance paracrine potency of transplanted mesenchymal stem cells in intractable neonatal disorders.

Authors:  Won Soon Park; So Yoon Ahn; Se In Sung; Jee-Yin Ahn; Yun Sil Chang
Journal:  Pediatr Res       Date:  2017-11-01       Impact factor: 3.756

5.  Human mesenchymal stromal cell-derived extracellular vesicles attenuate aortic aneurysm formation and macrophage activation via microRNA-147.

Authors:  Michael Spinosa; Guanyi Lu; Gang Su; Sai Vineela Bontha; Ricardo Gehrau; Morgan D Salmon; Joseph R Smith; Mark L Weiss; Valeria R Mas; Gilbert R Upchurch; Ashish K Sharma
Journal:  FASEB J       Date:  2018-05-29       Impact factor: 5.191

Review 6.  Cell-based secondary prevention of childbirth-induced pelvic floor trauma.

Authors:  Geertje Callewaert; Marina Monteiro Carvalho Mori Da Cunha; Nikhil Sindhwani; Maurilio Sampaolesi; Maarten Albersen; Jan Deprest
Journal:  Nat Rev Urol       Date:  2017-04-04       Impact factor: 14.432

7.  Intranasal MSC-derived A1-exosomes ease inflammation, and prevent abnormal neurogenesis and memory dysfunction after status epilepticus.

Authors:  Qianfa Long; Dinesh Upadhya; Bharathi Hattiangady; Dong-Ki Kim; Su Yeon An; Bing Shuai; Darwin J Prockop; Ashok K Shetty
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-10       Impact factor: 11.205

Review 8.  Inflammation, fibrosis, and modulation of the process by mesenchymal stem/stromal cells.

Authors:  Darwin J Prockop
Journal:  Matrix Biol       Date:  2016-01-22       Impact factor: 11.583

9.  Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes.

Authors:  Nahal Mansouri; Gareth R Willis; Angeles Fernandez-Gonzalez; Monica Reis; Sina Nassiri; S Alex Mitsialis; Stella Kourembanas
Journal:  JCI Insight       Date:  2019-11-01

10.  microRNAs and connexins in bone: interaction and mechanisms of delivery.

Authors:  Lilian I Plotkin; Rafael Pacheco-Costa; Hannah M Davis
Journal:  Curr Mol Biol Rep       Date:  2017-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.